Scientific Literature Search

Open access

Intrathecal Autologous Bone Marrow-Derived Hematopoietic Stem Cell Therapy in Neurological Diseases.

Zakerinia M, Kamgarpour A, Nemati H, Zare HR, Ghasemfar M, Rezvani AR, Karimi M, Nourani Khojasteh H, Dehghani M, Vojdani R, Haghighat S, Namdari N, Rekabpoor J, Tavazo M, Amirghofran S, Amirghofran Z, Yosefipour GA, Ramzi M.

Int J Organ Transplant Med · 2018-11-01

PMID: 30863518

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson's disease.

Jiang Y, Zhang X, Mu H, Hua H, Duan D, Yan X, Wang Y, Meng Q, Lu X, Wang A, Liu W, Li Y, Sun K.

Drug Deliv · 2018-11-01

DOI: 10.1080/10717544.2017.1419514PMID: 29275639

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Efficient treatment of Parkinson's disease using ultrasonography-guided rhFGF20 proteoliposomes.

Niu J, Xie J, Guo K, Zhang X, Xia F, Zhao X, Song L, Zhuge D, Li X, Zhao Y, Huang Z.

Drug Deliv · 2018-11-01

DOI: 10.1080/10717544.2018.1482972PMID: 30043675

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Nighttime Sleep and Daytime Sleepiness Improved With Pimavanserin During Treatment of Parkinson's Disease Psychosis.

Patel N, LeWitt P, Neikrug AB, Kesslak P, Coate B, Ancoli-Israel S.

Clin Neuropharmacol · 2018-11-01

DOI: 10.1097/wnf.0000000000000307PMID: 30303817

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly.

Estevez-Fraga C, Zeun P, López-Sendón Moreno JL.

Drugs Aging · 2018-11-01

DOI: 10.1007/s40266-018-0590-yPMID: 30357723

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

Angiopoietin-1 and ανβ3 integrin peptide promote the therapeutic effects of L-serine in an amyotrophic lateral sclerosis/Parkinsonism dementia complex model.

Cai HY, Tian KW, Zhang YY, Jiang H, Han S.

Aging (Albany NY) · 2018-11-01

DOI: 10.18632/aging.101661PMID: 30476904

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivity.

Niethammer M, Tang CC, Vo A, Nguyen N, Spetsieris P, Dhawan V, Ma Y, Small M, Feigin A, During MJ, Kaplitt MG, Eidelberg D.

Sci Transl Med · 2018-11-01

DOI: 10.1126/scitranslmed.aau0713PMID: 30487248

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[The treatment of advanced Parkinson's disease].

Klivényi P, Vécsei L.

Ideggyogy Sz · 2018-11-01

DOI: 10.18071/isz.71.0377PMID: 30604936

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease.

Rahman SO, Singh RK, Hussain S, Akhtar M, Najmi AK.

Eur J Pharmacol · 2018-10-30

DOI: 10.1016/j.ejphar.2018.10.040PMID: 30389631

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Open access

"Cell-addictive" dual-target traceable nanodrug for Parkinson's disease treatment via flotillins pathway.

Li Y, Chen Z, Lu Z, Yang Q, Liu L, Jiang Z, Zhang L, Zhang X, Qing H.

Theranostics · 2018-10-29

DOI: 10.7150/thno.28295PMID: 30555558

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

The key role of T cells in Parkinson's disease pathogenesis and therapy.

Baird JK, Bourdette D, Meshul CK, Quinn JF.

Parkinsonism Relat Disord · 2018-10-28

DOI: 10.1016/j.parkreldis.2018.10.029PMID: 30404763

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Dorsal striatum does not mediate feedback-based, stimulus-response learning: An event-related fMRI study in patients with Parkinson's disease tested on and off dopaminergic therapy.

Hiebert NM, Owen AM, Ganjavi H, Mendonça D, Jenkins ME, Seergobin KN, MacDonald PA.

Neuroimage · 2018-10-27

DOI: 10.1016/j.neuroimage.2018.10.045PMID: 30394326

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

20.760 articles found

Intrathecal Autologous Bone Marrow-Derived Hematopoietic Stem Cell Therapy in Neurological Diseases.

Preparation and evaluation of injectable Rasagiline mesylate dual-controlled drug delivery system for the treatment of Parkinson's disease.

Efficient treatment of Parkinson's disease using ultrasonography-guided rhFGF20 proteoliposomes.

Nighttime Sleep and Daytime Sleepiness Improved With Pimavanserin During Treatment of Parkinson's Disease Psychosis.

Current Methods for the Treatment and Prevention of Drug-Induced Parkinsonism and Tardive Dyskinesia in the Elderly.

Angiopoietin-1 and ανβ3 integrin peptide promote the therapeutic effects of L-serine in an amyotrophic lateral sclerosis/Parkinsonism dementia complex model.

Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivity.

[The treatment of advanced Parkinson's disease].

A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease.

"Cell-addictive" dual-target traceable nanodrug for Parkinson's disease treatment via flotillins pathway.

The key role of T cells in Parkinson's disease pathogenesis and therapy.

Dorsal striatum does not mediate feedback-based, stimulus-response learning: An event-related fMRI study in patients with Parkinson's disease tested on and off dopaminergic therapy.

Filters